Gazmend Temaj1*, Shefki Xharra2, Kumrije Sopi2, Hilada Nefic3, Angelika Moder4 and Rifat Hadziselimovic3
1Faculty of Pharmacy, University for Business and Technology, Kosovo
2Regional Hospital, Prizren, Kosovo
3Faculty of Natural Sciences, University of Sarajevo, Bosnia and Herzegovina
4Medical Faculty, Paracelsus Medical University, Austria
*Corresponding Author: Gazmend Temaj, Faculty of Pharmacy, University for Business and Technology, Kosovo.
Received: November 11, 2019; Published: December 06, 2019
Zinc finger protein 384 (ZNF384) fusion is good indicator in diagnosis; furthermore, ZNF384-rearregment is prevalent in mixed-phenotype acute leukemias. Last time is reported fusion of ZNF384 with 7 other partners in ALL. It is reviews in details the type the types of chromosomal aberrations, their background correlation with immunophenotype and distribution and their prognostic relevance.
KeywordsAcute Lymphoblastic Leukemia; B-Cell; ZNF384; Gene Fusion; Ewing Sarcomas
Citation: Gazmend Temaj., et al. "Fusion of ZNF384 with Different Genes at Acute Lymphoblastic Leukemia Patients".Acta Scientific Cancer Biology 4.1 (2020): 34-37.
Copyright: © 2020 Gazmend Temaj., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.